Log in to save to my catalogue

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2727637725

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify

About this item

Full title

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2022-11, Vol.41 (48), p.5160-5175

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Acute myeloid leukaemia (AML) is a rapidly fatal blood cancer that is characterised by the accumulation of immature myeloid cells in the blood and bone marrow as a result of blocked differentiation. Methods which identify master transcriptional regulators of AML subtype-specific leukaemia cell states and their combinations could be critical for dis...

Alternative Titles

Full title

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2727637725

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2727637725

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-022-02505-5

How to access this item